HK
TEVA icon

Horizon Kinetics’s Teva Pharmaceuticals TEVA Stock Holding History

Horizon Kinetics’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,782
Closed -$827K – 530
2014
Q2 		$827K Sell
15,782
-771
-5% -$39.4K 0.01% 276
2014
Q1 		$875K Buy
16,553
+2,651
+19% +$123K 0.01% 265
2013
Q4 		$557K Buy
13,902
+4,442
+47% +$175K 0.01% 323
2013
Q3 		$357K Buy
+9,460
New +$369K ﹤0.01% 358

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Horizon Kinetics's TEVA Position: Q3 2014 in Review

Horizon Kinetics sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 15,782 shares — an estimated $827K sold.

Horizon Kinetics first reported a position in TEVA in Q3 2013 and held it in 4 quarters. The position peaked at $875K in Q1 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Horizon Kinetics reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Horizon Kinetics sold 15,782 Teva Pharmaceuticals shares in Q3 2014, an estimated $827K.
  • Horizon Kinetics first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Horizon Kinetics's Teva Pharmaceuticals position peaked at $875K in Q1 2014.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Horizon Kinetics's 13F filing for Q3 2014, filed 13 Nov 2014.